Stay updated on Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page's Revision label was updated from v3.5.3 to v3.5.4, signaling a new maintained version of the page for internal tracking and QA.
    Difference
    0.0%
    Check dated 2026-05-17T05:29:14.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a newer system revision (from v3.5.2 to v3.5.3), without changing the displayed study information.
    Difference
    0.0%
    Check dated 2026-04-25T17:52:30.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:14:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision metadata updated to show v3.5.0, replacing the older v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-20T19:49:08.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The revision stamp in the page footer was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T16:40:54.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. No changes to study data, eligibility criteria, or navigation.
    Difference
    0.0%
    Check dated 2026-02-12T23:07:32.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Cabozantinib in Non-Clear Cell RCC Clinical Trial page.